Migraine-associated hypotension and autonomic ganglionitis
Citation Manager Formats
Make Comment
See Comments
![Loading Loading](https://n.neurology.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Reply from the Authors: The patient described in our article1 had recurrent migraine-associated vasomotor collapse and resistant hypertension when he was migraine free. The goal of treatment was to prevent migraine attacks and to control hypertension. Drugs used for the prevention of migraine are classified in four distinct groups: serotoninergic, beta-adrenergic blockers, alpha-2 adrenergic agonists, and calcium channel blockers. Unfortunately, his migraine did not respond to any …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Special Articles
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adultsReport of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyS.D. Silberstein, S. Holland, F. Freitag et al.Neurology, April 23, 2012 -
Special Article
Practice guideline update summary: Pharmacologic treatment for pediatric migraine preventionReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache SocietyMaryam Oskoui, Tamara Pringsheim, Lori Billinghurst et al.Neurology, August 14, 2019 -
BRIEF COMMUNICATIONS
Autonomic ganglionitis with severe hypertension, migraine, and episodic but fatal hypotensionH.-C. Lee, C. L. Coulter, E. D. Adickes et al.Neurology, September 01, 1996 -
Articles
Contemporary concepts of migraine pathogenesisK.M. A. Welch et al.Neurology, October 27, 2003